The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there were dozens in academia now they come with greater risk of course right no these are slight variations on what's currently using that clinic and different companies are using different vectors so av9 it's good for muscles so companies are going for muscular dystrophy with AV 9 AV 11 and 2 or good for the eye there's a menu now of dozens but there briefly I'll still adenovirus
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.